Passage Bio, Inc. (PASG) — Analyst estimates
Consensus analyst estimates for Passage Bio, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 0 | -2.69 | 1 |
| 2027 | 45.01M | -9.7 | 2 |
| 2028 | 31.53M | -8.87 | 2 |
| 2029 | 15.03M | -10.18 | 1 |
| 2030 | 42.72M | -9.8 | 1 |
Consensus analyst estimates by fiscal year.